Tris Pharma, Inc. - Product Pipeline Review - 2014

Published: Oct, 2014 | Pages: 31 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Tris Pharma, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Tris Pharma, Inc. - Product Pipeline Review - 2014', provides an overview of the Tris Pharma, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Tris Pharma, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Tris Pharma, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Tris Pharma, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Tris Pharma, Inc.'s pipeline products

Reasons to buy

- Evaluate Tris Pharma, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Tris Pharma, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Tris Pharma, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Tris Pharma, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Tris Pharma, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Tris Pharma, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Tris Pharma, Inc. Snapshot 5
Tris Pharma, Inc. Overview 5
Key Information 5
Key Facts 5
Tris Pharma, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Tris Pharma, Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Tris Pharma, Inc. - Pipeline Products Glance 11
Tris Pharma, Inc. - Late Stage Pipeline Products 11
Pre-Registration Products/Combination Treatment Modalities 11
Phase III Products/Combination Treatment Modalities 12
Tris Pharma, Inc. - Clinical Stage Pipeline Products 13
Phase I Products/Combination Treatment Modalities 13
Tris Pharma, Inc. - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Tris Pharma, Inc. - Unknown Stage Pipeline Products 15
Unknown Products/Combination Treatment Modalities 15
Tris Pharma, Inc. - Drug Profiles 16
CCP-01 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
TRI-102 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
CCP-07 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
CCP-08 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
CCP-05 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
CCP-06 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
TRI-091 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
TRI-096 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Tris Pharma, Inc. - Pipeline Products by Route of Administration 24
Tris Pharma, Inc. - Pipeline Products by Molecule Type 25
Tris Pharma, Inc. - Recent Pipeline Updates 26
Tris Pharma, Inc. - Dormant Projects 27
Tris Pharma, Inc. - Company Statement 28
Tris Pharma, Inc. - Locations And Subsidiaries 29
Head Office 29
Appendix 30
Methodology 30
Coverage 30
Secondary Research 30
Primary Research 30
Expert Panel Validation 30
Contact Us 31
Disclaimer 31

List of Tables
Tris Pharma, Inc., Key Information 5
Tris Pharma, Inc., Key Facts 5
Tris Pharma, Inc. - Pipeline by Indication, 2014 8
Tris Pharma, Inc. - Pipeline by Stage of Development, 2014 9
Tris Pharma, Inc. - Monotherapy Products in Pipeline, 2014 10
Tris Pharma, Inc. - Pre-Registration, 2014 11
Tris Pharma, Inc. - Phase III, 2014 12
Tris Pharma, Inc. - Phase I, 2014 13
Tris Pharma, Inc. - Preclinical, 2014 14
Tris Pharma, Inc. - Unknown, 2014 15
Tris Pharma, Inc. - Pipeline by Route of Administration, 2014 24
Tris Pharma, Inc. - Pipeline by Molecule Type, 2014 25
Tris Pharma, Inc. - Recent Pipeline Updates, 2014 26
Tris Pharma, Inc. - Dormant Developmental Projects,2014 27